Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Feb;35(2):145–149. doi: 10.1136/gut.35.2.145

Cholera and severe toxigenic diarrhoeas.

D R Nalin 1
PMCID: PMC1374485  PMID: 8307461

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akbar M. S., Baker K. M., Aziz M. A., Khan W. A., Salim A. F. A randomised, double-blind clinical trial of a maltodextrin containing oral rehydration solution in acute infantile diarrhoea. J Diarrhoeal Dis Res. 1991 Mar;9(1):33–37. [PubMed] [Google Scholar]
  2. Aksamit R. R., Backlund P. S., Jr, Cantoni G. L. Cholera toxin inhibits chemotaxis by a cAMP-independent mechanism. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7475–7479. doi: 10.1073/pnas.82.22.7475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Albert M. J., Siddique A. K., Islam M. S., Faruque A. S., Ansaruzzaman M., Faruque S. M., Sack R. B. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet. 1993 Mar 13;341(8846):704–704. doi: 10.1016/0140-6736(93)90481-u. [DOI] [PubMed] [Google Scholar]
  4. Ali M. Y. Investigation on fish diseases and parasites in East Pakistan. Bull Off Int Epizoot. 1968 Sep-Oct;69(9):1517–1521. [PubMed] [Google Scholar]
  5. Asano T., Murai M., Nakamura H. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts. Transplant Proc. 1993 Feb;25(1 Pt 1):761–762. [PubMed] [Google Scholar]
  6. Azurin J. C., Cruz A., Pesigan T. P., Alvero M., Camena T., Suplido R., Ledesma L., Gomez C. Z. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. Bull World Health Organ. 1967;37(5):703–727. [PMC free article] [PubMed] [Google Scholar]
  7. Barrett K. E., Bigby T. D. Involvement of arachidonic acid in the chloride secretory response of intestinal epithelial cells. Am J Physiol. 1993 Feb;264(2 Pt 1):C446–C452. doi: 10.1152/ajpcell.1993.264.2.C446. [DOI] [PubMed] [Google Scholar]
  8. Beubler E., Horina G. 5-HT2 and 5-HT3 receptor subtypes mediate cholera toxin-induced intestinal fluid secretion in the rat. Gastroenterology. 1990 Jul;99(1):83–89. doi: 10.1016/0016-5085(90)91233-v. [DOI] [PubMed] [Google Scholar]
  9. Bhan M. K., Ghai O. P., Khoshoo V., Vasudev A. S., Bhatnagar S., Arora N. K., Rashmi, Stintzing G. Efficacy of mung bean (lentil) and pop rice based rehydration solutions in comparison with the standard glucose electrolyte solution. J Pediatr Gastroenterol Nutr. 1987 May-Jun;6(3):392–399. doi: 10.1097/00005176-198705000-00016. [DOI] [PubMed] [Google Scholar]
  10. Briseid G., Briseid K., Kirkevold K. Increased intestinal absorption in the rat caused by sodium lauryl sulphate, and its possible relation to the cAMP system. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):137–144. doi: 10.1007/BF00498584. [DOI] [PubMed] [Google Scholar]
  11. Cash R. A., Forrest J. N., Nalin D. R., Abrutyn E. Rapid correction of acidosis and dehydration of cholera with oral electrolyte and glucose solution. Lancet. 1970 Sep 12;2(7672):549–550. doi: 10.1016/s0140-6736(70)91350-4. [DOI] [PubMed] [Google Scholar]
  12. Cash R. A., Nalin D. R., Rochat R., Reller L. B., Haque Z. A., Rahman A. S. A clinical trial of oral therapy in a rural cholera-treatment center. Am J Trop Med Hyg. 1970 Jul;19(4):653–656. doi: 10.4269/ajtmh.1970.19.653. [DOI] [PubMed] [Google Scholar]
  13. Cassuto J., Fahrenkrug J., Jodal M., Tuttle R., Lundgren O. Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. Gut. 1981 Nov;22(11):958–963. doi: 10.1136/gut.22.11.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Challacombe D. N., Wheeler E. E. Trophic action of epidermal growth factor on human duodenal mucosa cultured in vitro. Gut. 1991 Sep;32(9):991–993. doi: 10.1136/gut.32.9.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chang F. H., Bourne H. R. Cholera toxin induces cAMP-independent degradation of Gs. J Biol Chem. 1989 Apr 5;264(10):5352–5357. [PubMed] [Google Scholar]
  16. Chen L. C., Rohde J. E., Sharp G. W. Intestinal adenyl-cyclase activity in human cholera. Lancet. 1971 May 8;1(7706):939–941. doi: 10.1016/s0140-6736(71)91443-7. [DOI] [PubMed] [Google Scholar]
  17. Cholera research: What next. Lancet. 1976 Dec 11;2(7998):1283–1284. [PubMed] [Google Scholar]
  18. Clancy B. M., Czech M. P. Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes. J Biol Chem. 1990 Jul 25;265(21):12434–12443. [PubMed] [Google Scholar]
  19. Clemens J. D., Sack D. A., Harris J. R., Chakraborty J., Khan M. R., Huda S., Ahmed F., Gomes J., Rao M. R., Svennerholm A. M. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J Infect Dis. 1989 Apr;159(4):770–773. doi: 10.1093/infdis/159.4.770. [DOI] [PubMed] [Google Scholar]
  20. Clemens J. D., Sack D. A., Harris J. R., Van Loon F., Chakraborty J., Ahmed F., Rao M. R., Khan M. R., Yunus M., Huda N. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet. 1990 Feb 3;335(8684):270–273. doi: 10.1016/0140-6736(90)90080-o. [DOI] [PubMed] [Google Scholar]
  21. Cremaschi D., James P. S., Meyer G., Rossetti C., Smith M. W. Intracellular potassium as a possible inducer of amino acid transport across hamster jejunal enterocytes. J Physiol. 1986 Jun;375:107–119. doi: 10.1113/jphysiol.1986.sp016108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Csáky T. Z., Esposito G., Faelli A., Capraro V. Stimulation of the water transport in the jejunum of the rat by ethyl acetate. Proc Soc Exp Biol Med. 1971 Jan;136(1):242–244. doi: 10.3181/00379727-136-35236. [DOI] [PubMed] [Google Scholar]
  23. Debnam E. S., Sharp P. A. Acute and chronic effects of pancreatic glucagon on sugar transport across the brush-border and basolateral membranes of rat jejunal enterocytes. Exp Physiol. 1993 Mar;78(2):197–207. doi: 10.1113/expphysiol.1993.sp003680. [DOI] [PubMed] [Google Scholar]
  24. Farack U. M., Kautz U., Loeschke K. Loperamide reduces the intestinal secretion but not the mucosal cAMP accumulation induced by choleratoxin. Naunyn Schmiedebergs Arch Pharmacol. 1981 Sep;317(2):178–179. doi: 10.1007/BF00500077. [DOI] [PubMed] [Google Scholar]
  25. Field M. Intestinal electrolyte secretion. History of a paradigm. Arch Surg. 1993 Mar;128(3):273–278. doi: 10.1001/archsurg.1993.01420150027005. [DOI] [PubMed] [Google Scholar]
  26. Field M., Semrad C. E. Toxigenic diarrheas, congenital diarrheas, and cystic fibrosis: disorders of intestinal ion transport. Annu Rev Physiol. 1993;55:631–655. doi: 10.1146/annurev.ph.55.030193.003215. [DOI] [PubMed] [Google Scholar]
  27. Finkelstein R. A. Combating epidemic cholera. Science. 1992 Aug 14;257(5072):862–862. doi: 10.1126/science.1502547. [DOI] [PubMed] [Google Scholar]
  28. Gore S. M., Fontaine O., Pierce N. F. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ. 1992 Feb 1;304(6822):287–291. doi: 10.1136/bmj.304.6822.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Haack B. M., Emmrich F., Resch K. Cholera toxin inhibits T cell receptor signaling by covalent modification of the CD3-zeta subunit. J Immunol. 1993 Apr 1;150(7):2599–2606. [PubMed] [Google Scholar]
  30. Hallbäck D. A., Jodal M., Sjöqvist A., Lundgren O. Evidence for cholera secretion emanating from the crypts. A study of villus tissue osmolality and fluid and electrolyte transport in the small intestine of the cat. Gastroenterology. 1982 Nov;83(5):1051–1056. [PubMed] [Google Scholar]
  31. Harvey R. M., Enson Y., Lewis M. L., Greenough W. B., Ally K. M., Panno R. A. Hemodynamic effects of dehydration and metabolic acidosis in Asiatic cholera. Trans Assoc Am Physicians. 1966;79:177–186. [PubMed] [Google Scholar]
  32. Hazzard C. E., Ahearn G. A. Rapid stimulation of intestinal D-glucose transport in teleosts by 17 alpha-methyltestosterone. Am J Physiol. 1992 Mar;262(3 Pt 2):R412–R418. doi: 10.1152/ajpregu.1992.262.3.R412. [DOI] [PubMed] [Google Scholar]
  33. Heitlinger L. A., Sloan H. R., DeVore D. R., Lee P. C., Lebenthal E., Duffey M. E. Transport of glucose polymer-derived glucose by rabbit jejunum. Gastroenterology. 1992 Feb;102(2):443–447. doi: 10.1016/0016-5085(92)90088-g. [DOI] [PubMed] [Google Scholar]
  34. Hirayama T., Noda M., Ito H., Takeda Y. Stimulation of phosphorylation of rat brush-border membrane proteins by Escherichia coli heat-stable enterotoxin, cholera enterotoxin and cyclic nucleotides, and its inhibition by protein kinase inhibitors, isoquinolinesulfonamides. Microb Pathog. 1990 Jun;8(6):421–431. doi: 10.1016/0882-4010(90)90029-p. [DOI] [PubMed] [Google Scholar]
  35. Holmgren J., Czerkinsky C. Cholera as a model for research on mucosal immunity and development of oral vaccines. Curr Opin Immunol. 1992 Aug;4(4):387–391. doi: 10.1016/s0952-7915(06)80027-0. [DOI] [PubMed] [Google Scholar]
  36. Honda T., Arita M., Takeda T., Yoh M., Miwatani T. Non-O1 Vibrio cholerae produces two newly identified toxins related to Vibrio parahaemolyticus haemolysin and Escherichia coli heat-stable enterotoxin. Lancet. 1985 Jul 20;2(8447):163–164. doi: 10.1016/s0140-6736(85)90277-6. [DOI] [PubMed] [Google Scholar]
  37. Hunt J. B., Carnaby S., Farthing M. J. Assessment of water and solute absorption from experimental hypotonic and established oral rehydration solutions in secreting rat intestine. Aliment Pharmacol Ther. 1991 Jun;5(3):273–281. doi: 10.1111/j.1365-2036.1991.tb00028.x. [DOI] [PubMed] [Google Scholar]
  38. Huq A., Huq S. A., Grimes D. J., O'Brien M., Chu K. H., Capuzzo J. M., Colwell R. R. Colonization of the gut of the blue crab (Callinectes sapidus) by Vibrio cholerae. Appl Environ Microbiol. 1986 Sep;52(3):586–588. doi: 10.1128/aem.52.3.586-588.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Huq A., Small E. B., West P. A., Huq M. I., Rahman R., Colwell R. R. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol. 1983 Jan;45(1):275–283. doi: 10.1128/aem.45.1.275-283.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Huq A., West P. A., Small E. B., Huq M. I., Colwell R. R. Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar 01 associated with live copepods in laboratory microcosms. Appl Environ Microbiol. 1984 Aug;48(2):420–424. doi: 10.1128/aem.48.2.420-424.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Hyun C. S., Kimmich G. A. Effect of cholera toxin on cAMP levels and Na+ influx in isolated intestinal epithelial cells. Am J Physiol. 1982 Sep;243(3):C107–C115. doi: 10.1152/ajpcell.1982.243.3.C107. [DOI] [PubMed] [Google Scholar]
  42. Irvine F. J., Houslay M. D. Insulin and glucagon attenuate the ability of cholera toxin to activate adenylate cyclase in intact hepatocytes. Biochem J. 1988 Apr 15;251(2):447–452. doi: 10.1042/bj2510447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Islam M. R., Ahmed S. M. Oral rehydration solution without bicarbonate. Arch Dis Child. 1984 Nov;59(11):1072–1075. doi: 10.1136/adc.59.11.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Islam M. R., Sack D. A., Holmgren J., Bardhan P. K., Rabbani G. H. The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases. Gastroenterology. 1982 Jun;82(6):1335–1340. [PubMed] [Google Scholar]
  45. Islam M. S., Drasar B. S., Bradley D. J. Long-term persistence of toxigenic Vibrio cholerae 01 in the mucilaginous sheath of a blue-green alga, Anabaena variabilis. J Trop Med Hyg. 1990 Apr;93(2):133–139. [PubMed] [Google Scholar]
  46. Islam M. S., Drasar B. S., Bradley D. J. Survival of toxigenic Vibrio cholerae O1 with a common duckweed, Lemna minor, in artificial aquatic ecosystems. Trans R Soc Trop Med Hyg. 1990 May-Jun;84(3):422–424. doi: 10.1016/0035-9203(90)90345-f. [DOI] [PubMed] [Google Scholar]
  47. Iwanaga M., Nakasone N., Yamashiro T., Higa N. Pili of vibrio cholerae widely distributed in serogroup O1 strains. Microbiol Immunol. 1993;37(1):23–28. doi: 10.1111/j.1348-0421.1993.tb03174.x. [DOI] [PubMed] [Google Scholar]
  48. Iwaz J., Lafont S., Revillard J. P. Elevation of cyclic 3'5' adenosine monophosphate levels by cholera toxin inhibits the generation of interleukin 2 activity. Cell Immunol. 1986 Dec;103(2):455–461. doi: 10.1016/0008-8749(86)90105-x. [DOI] [PubMed] [Google Scholar]
  49. Janicot M., Clot J. P., Desbuquois B. Interactions of cholera toxin with isolated hepatocytes. Effects of low pH, chloroquine and monensin on toxin internalization, processing and action. Biochem J. 1988 Aug 1;253(3):735–743. doi: 10.1042/bj2530735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Kenya P. R., Odongo H. W., Oundo G., Waswa K., Muttunga J., Molla A. M., Nath S. K., Molla A., Greenough W. B., 3rd, Juma R. Cereal based oral rehydration solutions. Arch Dis Child. 1989 Jul;64(7):1032–1035. doi: 10.1136/adc.64.7.1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Khin-Maung-U, Bolin T. D., Duncombe V. M., Myo-Khin, Nyunt-Nyunt-Wai, Pereira S. P., Linklater J. M. Epidemiology of small bowel bacterial overgrowth and rice carbohydrate malabsorption in Burmese (Myanmar) village children. Am J Trop Med Hyg. 1992 Sep;47(3):298–304. doi: 10.4269/ajtmh.1992.47.298. [DOI] [PubMed] [Google Scholar]
  52. Khin-Maung-U, Myo-Khin, Nyunt-Nyunt-Wai, Mu-Mu-Khin, Mya-Thi, Thein-Thein-Myint Comparison of glucose/electrolyte and maltodextrin/glycine/glycyl-glycine/electrolyte oral rehydration solutions in acute diarrhea in children. J Pediatr Gastroenterol Nutr. 1991 Nov;13(4):397–401. doi: 10.1097/00005176-199111000-00010. [DOI] [PubMed] [Google Scholar]
  53. Khin-Maung-U, Myo-Khin, Nyunt-Nyunt-Wai, Tin-U Comparison of glucose/electrolyte and maltodextrin/glycine/glycyl-glycine/electrolyte oral rehydration solutions in cholera and watery diarrhoea in adults. Ann Trop Med Parasitol. 1991 Dec;85(6):645–650. doi: 10.1080/00034983.1991.11812620. [DOI] [PubMed] [Google Scholar]
  54. Khin-Maung-U, Nyunt-Nyunt-Wai, Myo-Khin, Mu-Mu-Khin, Tin-U, Thane-Toe Effect of boiled-rice feeding in childhood cholera on clinical outcome. Hum Nutr Clin Nutr. 1986 Jul;40(4):249–254. [PubMed] [Google Scholar]
  55. Khoshoo V., Bhan M. K., Jain R., Jayashree S., Bhandari N., Sazawal S., Mathur M. Intestinal glucoamylase & other disaccharidases in children with protracted diarrhoea. Indian J Med Res. 1990 Feb;92:1–4. [PubMed] [Google Scholar]
  56. Kiiyukia C., Nakajima A., Nakai T., Muroga K., Kawakami H., Hashimoto H. Vibrio cholerae non-O1 isolated from ayu fish (Plecoglossus altivelis) in Japan. Appl Environ Microbiol. 1992 Sep;58(9):3078–3082. doi: 10.1128/aem.58.9.3078-3082.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Kim D. K., Nau G. J., Lancki D. W., Dawson G., Fitch F. W. Cholera toxin discriminates between murine T lymphocyte proliferation stimulated by activators of protein kinase C and proliferation stimulated by IL-2. Possible role for intracellular cAMP. J Immunol. 1988 Nov 15;141(10):3429–3437. [PubMed] [Google Scholar]
  58. Kinzie J. L., Ferrendelli J. A., Alpers D. H. Adenosine cyclic 3':5'-monophosphate-mediated transport of neutral and dibasic amino acids in jejunal mucosa. J Biol Chem. 1973 Oct 25;248(20):7018–7024. [PubMed] [Google Scholar]
  59. Kirchgessner M., Plank J., Roth H. P. Zum Einfluss von alimentärem Zinkmangel auf den Vitamin-A- und alpha-Tocopherol-Stoffwechsel bei Ratten. Z Ernahrungswiss. 1987 Mar;26(1):1–6. doi: 10.1007/BF02023815. [DOI] [PubMed] [Google Scholar]
  60. Kothary M. H., Richardson S. H. Fluid accumulation in infant mice caused by Vibrio hollisae and its extracellular enterotoxin. Infect Immun. 1987 Mar;55(3):626–630. doi: 10.1128/iai.55.3.626-630.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Krasilnikov O. V., Muratkhodjaev J. N., Voronov S. E., Yezepchuk Y. V. The ionic channels formed by cholera toxin in planar bilayer lipid membranes are entirely attributable to its B-subunit. Biochim Biophys Acta. 1991 Aug 26;1067(2):166–170. doi: 10.1016/0005-2736(91)90039-b. [DOI] [PubMed] [Google Scholar]
  62. Lange S., Lönnroth I. Bile and milk from cholera toxin treated rats contain a hormone-like factor which inhibits diarrhea induced by the toxin. Int Arch Allergy Appl Immunol. 1986;79(3):270–275. doi: 10.1159/000233985. [DOI] [PubMed] [Google Scholar]
  63. Levine M. M., Kaper J. B. Live oral vaccines against cholera: an update. Vaccine. 1993;11(2):207–212. doi: 10.1016/0264-410x(93)90019-t. [DOI] [PubMed] [Google Scholar]
  64. Lindfors A., Lundberg B., Stenhammar L. Glucose polymers in diarrhoea--risk of hypernatraemia. Acta Paediatr. 1992 Jan;81(1):73–74. doi: 10.1111/j.1651-2227.1992.tb12083.x. [DOI] [PubMed] [Google Scholar]
  65. Longbottom D., van Heyningen S. Effect of antipsychotic drugs on the molecular action of cholera toxin in rabbit intestinal epithelial cells. FEBS Lett. 1990 Oct 15;272(1-2):41–44. doi: 10.1016/0014-5793(90)80444-n. [DOI] [PubMed] [Google Scholar]
  66. Lönnroth I., Martinsson K., Lange S. Evidence of protection against diarrhoea in suckling piglets by a hormone-like protein in the sow's milk. Zentralbl Veterinarmed B. 1988 Oct;35(8):628–635. doi: 10.1111/j.1439-0450.1988.tb00537.x. [DOI] [PubMed] [Google Scholar]
  67. Macleod K. G., Milligan G. Biphasic regulation of adenylate cyclase by cholera toxin in neuroblastoma x glioma hybrid cells is due to the activation and subsequent loss of the alpha subunit of the stimulatory GTP binding protein (GS). Cell Signal. 1990;2(2):139–151. doi: 10.1016/0898-6568(90)90017-5. [DOI] [PubMed] [Google Scholar]
  68. Mahalanabis D., Patra F. C. In search of a super oral rehydration solution: can optimum use of organic solute-mediated sodium absorption lead to the development of an absorption promoting drug? J Diarrhoeal Dis Res. 1983 Jun;1(2):76–81. [PubMed] [Google Scholar]
  69. Mutoh T., Tokuda A., Guroff G., Fujiki N. The effect of the B subunit of cholera toxin on the action of nerve growth factor on PC12 cells. J Neurochem. 1993 Apr;60(4):1540–1547. doi: 10.1111/j.1471-4159.1993.tb03319.x. [DOI] [PubMed] [Google Scholar]
  70. Nalin D. R., Ally K., Hare R., Hare K. Effect of cholera toxin on jejunal osmoregulation of mannitol solutions in dogs. J Infect Dis. 1972 May;125(5):528–532. doi: 10.1093/infdis/125.5.528. [DOI] [PubMed] [Google Scholar]
  71. Nalin D. R., Bhattacharjee A. K., Richardson S. H. Cholera-like toxic effect of culture filtrates of Escherichia coli. J Infect Dis. 1974 Dec;130(6):595–607. doi: 10.1093/infdis/130.6.595. [DOI] [PubMed] [Google Scholar]
  72. Nalin D. R., Cash R. A., Islam R., Molla M., Phillips R. A. Oral maintenance therapy for cholera in adults. Lancet. 1968 Aug 17;2(7564):370–373. doi: 10.1016/s0140-6736(68)90591-6. [DOI] [PubMed] [Google Scholar]
  73. Nalin D. R., Cash R. A. Oral or nasogastric maintenance therapy for diarrhoea of unknown aetiology resembling cholera. Trans R Soc Trop Med Hyg. 1970;64(5):769–771. doi: 10.1016/0035-9203(70)90020-9. [DOI] [PubMed] [Google Scholar]
  74. Nalin D. R., Cash R. A., Rahman M., Yunus M. Effect of glycine and glucose on sodium and water adsorption in patients with cholera. Gut. 1970 Sep;11(9):768–772. doi: 10.1136/gut.11.9.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Nalin D. R. Cholera, copepods, and chitinase. Lancet. 1976 Oct 30;2(7992):958–958. doi: 10.1016/s0140-6736(76)90915-6. [DOI] [PubMed] [Google Scholar]
  76. Nalin D. R. Comparison of oral rehydration solutions. J Pediatr Gastroenterol Nutr. 1989 Feb;8(2):272–276. [PubMed] [Google Scholar]
  77. Nalin D. R., Daya V., Reid A., Levine M. M., Cisneros L. Adsorption and growth of Vibrio cholerae on chitin. Infect Immun. 1979 Aug;25(2):768–770. doi: 10.1128/iai.25.2.768-770.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Nalin D. R., Harland E., Ramlal A., Swaby D., McDonald J., Gangarosa R., Levine M., Akierman A., Antoine M., Mackenzie K. Comparison of low and high sodium and potassium content in oral rehydration solutions. J Pediatr. 1980 Nov;97(5):848–853. doi: 10.1016/s0022-3476(80)80287-3. [DOI] [PubMed] [Google Scholar]
  79. Nalin D. R., McLaughlin J. C., Rahaman M., Yunus M., Curlin G. Enterotoxigenic Escherichia coli and idiopathic diarrhoea in Bangladesh. Lancet. 1975 Dec 6;2(7945):1116–1119. doi: 10.1016/s0140-6736(75)91005-3. [DOI] [PubMed] [Google Scholar]
  80. Nashar T. O., Amin T., Marcello A., Hirst T. R. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine. 1993;11(2):235–240. doi: 10.1016/0264-410x(93)90023-q. [DOI] [PubMed] [Google Scholar]
  81. Niemialtowski M., Klucinski W., Malicki K., de Faundez I. S. Cholera toxin (choleragen)-polymorphonuclear leukocyte interactions: effect on migration in vitro and Fc gamma R-dependent phagocytic and bactericidal activity. Microbiol Immunol. 1993;37(1):55–62. doi: 10.1111/j.1348-0421.1993.tb03179.x. [DOI] [PubMed] [Google Scholar]
  82. Ogg J. E., Ryder R. A., Smith H. L., Jr Isolation of Vibrio cholerae from aquatic birds in Colorado and Utah. Appl Environ Microbiol. 1989 Jan;55(1):95–99. doi: 10.1128/aem.55.1.95-99.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Opleta-Madsen K., Hardin J., Gall D. G. Epidermal growth factor upregulates intestinal electrolyte and nutrient transport. Am J Physiol. 1991 Jun;260(6 Pt 1):G807–G814. doi: 10.1152/ajpgi.1991.260.6.G807. [DOI] [PubMed] [Google Scholar]
  84. Patra F. C., Sack D. A., Islam A., Alam A. N., Mazumder R. N. Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial. BMJ. 1989 May 20;298(6684):1353–1356. doi: 10.1136/bmj.298.6684.1353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Pierre P. G., Lucas G., Van Damme M., Vaerman J. P. Recent progress in cholera vaccination. Acta Gastroenterol Belg. 1992 Sep-Dec;55(5-6):430–436. [PubMed] [Google Scholar]
  86. Pines M., Ashkenazi A., Cohen-Chapnik N., Binder L., Gertler A. Inhibition of the proliferation of Nb2 cells by femtomolar concentrations of cholera toxin and partial reversal of the effect by 12-O-tetradecanoyl-phorbol-13-acetate. J Cell Biochem. 1988 May;37(1):119–129. doi: 10.1002/jcb.240370111. [DOI] [PubMed] [Google Scholar]
  87. Pizarro D., Posada G., Mahalanabis D., Sandí L. Comparison of efficacy of a glucose/glycine/glycylglycine electrolyte solution versus the standard WHO/ORS in diarrheic dehydrated children. J Pediatr Gastroenterol Nutr. 1988 Nov-Dec;7(6):882–888. doi: 10.1097/00005176-198811000-00016. [DOI] [PubMed] [Google Scholar]
  88. Prasad R., Chopra A. K., Peterson J. W., Pericas R., Houston C. W. Biological and immunological characterization of a cloned cholera toxin-like enterotoxin from Salmonella typhimurium. Microb Pathog. 1990 Nov;9(5):315–329. doi: 10.1016/0882-4010(90)90066-y. [DOI] [PubMed] [Google Scholar]
  89. Price H. V., Dodge J. A., Thomas M. K. Oral rehydration without added bicarbonate for childhood gastroenteritis. Br Med J (Clin Res Ed) 1984 Sep 1;289(6444):532–532. doi: 10.1136/bmj.289.6444.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Rabbani G. H., Butler T. Indomethacin and chloroquine fail to inhibit fluid loss in cholera. Gastroenterology. 1985 Nov;89(5):1035–1037. doi: 10.1016/0016-5085(85)90205-7. [DOI] [PubMed] [Google Scholar]
  91. Rabbani G. H., Greenough W. B., 3rd, Holmgren J., Kirkwood B. Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously. Br Med J (Clin Res Ed) 1982 May 8;284(6326):1361–1364. doi: 10.1136/bmj.284.6326.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Ramamurthy T., Garg S., Sharma R., Bhattacharya S. K., Nair G. B., Shimada T., Takeda T., Karasawa T., Kurazano H., Pal A. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet. 1993 Mar 13;341(8846):703–704. doi: 10.1016/0140-6736(93)90480-5. [DOI] [PubMed] [Google Scholar]
  93. Rivière F., Kay B. H., Klein J. M., Séchan Y. Mesocyclops aspericornis (Copepoda) and Bacillus thuringiensis var. israelensis for the biological control of Aedes and Culex vectors (Diptera: Culicidae) breeding in crab holes, tree holes, and artificial containers. J Med Entomol. 1987 Jul;24(4):425–430. doi: 10.1093/jmedent/24.4.425. [DOI] [PubMed] [Google Scholar]
  94. Rose J. M., Houston C. W., Coppenhaver D. H., Dixon J. D., Kurosky A. Purification and chemical characterization of a cholera toxin-cross-reactive cytolytic enterotoxin produced by a human isolate of Aeromonas hydrophila. Infect Immun. 1989 Apr;57(4):1165–1169. doi: 10.1128/iai.57.4.1165-1169.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Sachdev H. P., Mittal N. K., Mittal S. K., Yadav H. S. A controlled trial on utility of oral zinc supplementation in acute dehydrating diarrhea in infants. J Pediatr Gastroenterol Nutr. 1988 Nov-Dec;7(6):877–881. doi: 10.1097/00005176-198811000-00015. [DOI] [PubMed] [Google Scholar]
  96. Salmaso S., Greco D., Bonfiglio B., Castellani-Pastoris M., De Felip G., Bracciotti A., Sitzia G., Congiu A., Piu G., Angioni G. Recurrence of Pelecypod-associated cholera in Sardinia. Lancet. 1980 Nov 22;2(8204):1124–1127. doi: 10.1016/s0140-6736(80)92553-2. [DOI] [PubMed] [Google Scholar]
  97. Savarino S. J., Fasano A., Watson J., Martin B. M., Levine M. M., Guandalini S., Guerry P. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3093–3097. doi: 10.1073/pnas.90.7.3093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Schmaljohn C. S., Hasty S. E., Dalrymple J. M. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine. 1992;10(1):10–13. doi: 10.1016/0264-410x(92)90412-d. [DOI] [PubMed] [Google Scholar]
  99. Schorderet-Slatkine S., Schorderet M., Baulieu E. E. Cyclic AMP-mediated control of meiosis: effects of progesterone, cholera toxin, and membrane-active drugs in Xenopus laevis oocytes. Proc Natl Acad Sci U S A. 1982 Feb;79(3):850–854. doi: 10.1073/pnas.79.3.850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Sengupta D. K., Sengupta T. K., Ghose A. C. Major outer membrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization. Infect Immun. 1992 Nov;60(11):4848–4855. doi: 10.1128/iai.60.11.4848-4855.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Sepulveda J., Gomez-Dantes H., Bronfman M. Cholera in the Americas: an overview. Infection. 1992 Sep-Oct;20(5):243–248. doi: 10.1007/BF01710787. [DOI] [PubMed] [Google Scholar]
  102. Shimodori S., Moriya T., Kohashi O., Faming D., Amako K. Extraction from prawn shells of substances cryoprotective for Vibrio cholerae. Appl Environ Microbiol. 1989 Oct;55(10):2726–2728. doi: 10.1128/aem.55.10.2726-2728.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Sjöqvist A., Cassuto J., Jodal M., Lundgren O. Actions of serotonin antagonists on cholera-toxin-induced intestinal fluid secretion. Acta Physiol Scand. 1992 Jul;145(3):229–237. doi: 10.1111/j.1748-1716.1992.tb09360.x. [DOI] [PubMed] [Google Scholar]
  104. Sjöqvist A., Fahrenkrug J., Jodal M., Lundgren O. The effect of splanchnic nerve stimulation and neuropeptide Y on cholera secretion and release of vasoactive intestinal polypeptide in the feline small intestine. Acta Physiol Scand. 1988 Jul;133(3):289–295. doi: 10.1111/j.1748-1716.1988.tb08410.x. [DOI] [PubMed] [Google Scholar]
  105. Suntharasamai P., Migasena S., Vongsthongsri U., Supanaranond W., Pitisuttitham P., Supeeranan L., Chantra A., Naksrisook S. Clinical and bacteriological studies of El Tor cholera after ingestion of known inocula in Thai volunteers. Vaccine. 1992;10(8):502–505. doi: 10.1016/0264-410x(92)90347-m. [DOI] [PubMed] [Google Scholar]
  106. Tamplin M. L., Colwell R. R., Hall S., Kogure K., Strichartz G. R. Sodium-channel inhibitors produced by enteropathogenic Vibrio cholerae and Aeromonas hydrophila. Lancet. 1987 Apr 25;1(8539):975–975. doi: 10.1016/s0140-6736(87)90317-5. [DOI] [PubMed] [Google Scholar]
  107. Thom S., Warhurst D., Drasar B. S. Association of Vibrio cholerae with fresh water amoebae. J Med Microbiol. 1992 May;36(5):303–306. doi: 10.1099/00222615-36-5-303. [DOI] [PubMed] [Google Scholar]
  108. Van Loon F. P., Rabbani G. H., Bukhave K., Rask-Madsen J. Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera. Gut. 1992 May;33(5):643–645. doi: 10.1136/gut.33.5.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Walker-Smith J. A. Underutilisation of oral rehydration in the treatment of gastroenteritis. Drugs. 1988;36 (Suppl 4):61–64. doi: 10.2165/00003495-198800364-00009. [DOI] [PubMed] [Google Scholar]
  110. Yi-Yi-Myint, Khin-Maung-U, Aye-Kyaw, Zin-Thet-Khine, Kyi-Kyi-May Effect of cholera toxin on L-[14C]glycine uptake and intestinal cell enzymes in rabbit. Mol Biol Med. 1991 Feb;8(1):129–133. [PubMed] [Google Scholar]
  111. de Cremoux P., Zimber A., Calvo F., Lanotte M., Mercken L., Abita J. P. Gs alpha availability to cholera toxin-catalysed ADP-ribosylation is decreased in membranes of retinoic acid-treated leukemic cell lines HL-60 and THP-1. A posttranslational effect. Biochem Pharmacol. 1991 Nov 6;42(11):2141–2146. doi: 10.1016/0006-2952(91)90349-a. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES